Having trouble accessing articles? Reset your cache.

Management Tracks: CRISPR, Moderna

Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) hired Steve Caffé as head of regulatory affairs. Caffé was SVP at Ra Pharmaceuticals Inc. (NASDAQ:RARX).

mRNA company Moderna Therapeutics Inc. (Cambridge, Mass.) hired Megan Pace as chief

Read the full 349 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE